R H Osborne1, G R Elsworth, M A G Sprangers, F J Oort, J L Hopper. 1. Centre for Genetic Epidemiology, School of Population Health, The University of Melbourne, Royal Melbourne Hospital, Parkville, Australia. richardo@unimelb.edu.au
Abstract
BACKGROUND: The Hospital Anxiety and Depression Scale (HADS) is frequently used in cancer studies, yet its utility for comparing people with cancer with people in the community is uncertain. METHODS: HADS scores were obtained from population-based samples of women with (n = 731) and without (n = 158) early-onset breast cancer. Psychometric properties were examined using differential item functioning (DIF) which is the presence of systematic group differences in certain response items independent of the trait being measured. RESULTS: Women with breast cancer scored lower than reference women on anxiety (mean (SD) 7.5 (4.3) vs. 8.2 (4.0); p = 0.06) and depression (3.3 (3.2) vs. 4.2 (3.0); p = 0.003). Group differences remained following adjustment for demographics. Time since diagnosis was not related to anxiety or depression scores. DIF was present in two anxiety and five depression items. Adjustment for DIF did not substantially change the anxiety or depression group differences. CONCLUSION: Specific sampling or DIF effects do not explain the observation that women with breast cancer have lower levels of anxiety and depression than population controls. The psychometric properties of the HADS appear to be acceptable in these groups.
BACKGROUND: The Hospital Anxiety and Depression Scale (HADS) is frequently used in cancer studies, yet its utility for comparing people with cancer with people in the community is uncertain. METHODS: HADS scores were obtained from population-based samples of women with (n = 731) and without (n = 158) early-onset breast cancer. Psychometric properties were examined using differential item functioning (DIF) which is the presence of systematic group differences in certain response items independent of the trait being measured. RESULTS:Women with breast cancer scored lower than reference women on anxiety (mean (SD) 7.5 (4.3) vs. 8.2 (4.0); p = 0.06) and depression (3.3 (3.2) vs. 4.2 (3.0); p = 0.003). Group differences remained following adjustment for demographics. Time since diagnosis was not related to anxiety or depression scores. DIF was present in two anxiety and five depression items. Adjustment for DIF did not substantially change the anxiety or depression group differences. CONCLUSION: Specific sampling or DIF effects do not explain the observation that women with breast cancer have lower levels of anxiety and depression than population controls. The psychometric properties of the HADS appear to be acceptable in these groups.
Authors: L G Walker; S D Heys; M B Walker; K Ogston; I D Miller; A W Hutcheon; T K Sarkar; A K Ah-See; O Eremin Journal: Eur J Cancer Date: 1999-12 Impact factor: 9.162
Authors: Jeanne A Teresi; Katja Ocepek-Welikson; Marjorie Kleinman; Joseph P Eimicke; Paul K Crane; Richard N Jones; Jin-Shei Lai; Seung W Choi; Ron D Hays; Bryce B Reeve; Steven P Reise; Paul A Pilkonis; David Cella Journal: Psychol Sci Q Date: 2009
Authors: Reinhold Schwarz; Oliver Krauss; Michael Höckel; Alexandra Meyer; Markus Zenger; Andreas Hinz Journal: Breast Care (Basel) Date: 2008-12-05 Impact factor: 2.860
Authors: Tim Luckett; Phyllis N Butow; Madeleine T King; Mayumi Oguchi; Gaynor Heading; Nadine A Hackl; Nicole Rankin; Melanie A Price Journal: Support Care Cancer Date: 2010-07-02 Impact factor: 3.603
Authors: Judson B Williams; Karen P Alexander; Jean-François Morin; Yves Langlois; Nicolas Noiseux; Louis P Perrault; Kim Smolderen; Suzanne V Arnold; Mark J Eisenberg; Louise Pilote; Johanne Monette; Howard Bergman; Peter K Smith; Jonathan Afilalo Journal: Am J Cardiol Date: 2013-01-01 Impact factor: 2.778